A new, highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received $21.3 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. Developed at Northwestern University’s Center for Innovation in Global Health Technologies (CIGHT), the point-of-care technology is being commercialized by Northwestern spinoff company Minute Molecular Diagnostics, which will use the NIH grant to ramp up production to one million test cartridges per month.
